Results 31 to 40 of about 710,167 (255)
Sugammadex is a novel agent for the reversal of neuromuscular blockade. The speed and efficacy of reversal with sugammadex are significantly faster than acetylcholinesterase inhibitors, such as neostigmine.
Karen Miller +2 more
doaj +1 more source
Cholinesterase inhibitors have been the subject of many studies aimed at developing an effective treatment for various cognitive disorders. Therefore, studying cholinesterases and elucidating the mechanism of their interaction with ligands provide a ...
A.R. Mukhametgalieva +3 more
doaj +1 more source
Intranasal administration of acetylcholinesterase inhibitors [PDF]
This short review outlines the rationale, challenges, and opportunities for intranasal acetylcholinesterases, in particular galantamine. An in vitro screening model facilitated the development of a therapeutically viable formulation. In vivo testing confirmed achievement of therapeutically relevant drug levels that matched or exceeded those for oral ...
Costantino, Henry R +4 more
openaire +2 more sources
The inhibition of acetylcholinesterase plays a vital role in the treatment of Alzheimer disease. This study aimed to explore the acetylcholinesterase inhibition potential of Phyllanthus amarus and its phytoconstituents through an in vitro and in silico ...
Kolade O Faloye +10 more
doaj +1 more source
Sugammadex and recurarization in an infant. [PDF]
Sugammadex is a novel pharmacologic agent, which re- verses neuromuscular blockade via a mechanism that dif- fers completely from acetylcholinesterase inhibitors such as neostigmine.
J. Arends, J. D. Tobias
doaj +1 more source
Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer’s Disorders Using Molecular Docking and Molecular Dynamics Simulation [PDF]
Cholinesterase inhibitors (ChE-Is) are the standard for the therapy of AD associated disorders and are the only class of approved drugs by the Food and Drug Administration (FDA).
Kuldeep Uchadia +5 more
core +1 more source
The search for effective yet environmentally friendly strategies to prevent marine biofouling is hampered by the large taxonomic diversity amongst fouling organisms and a lack of well-defined conserved molecular targets.
Homayon John Arabshahi +7 more
doaj +1 more source
Objective Glycosylphosphatidylinositol (GPI)‐anchored proteins play critical roles in nervous system function. Pathogenic variants in genes involved in GPI‐anchor biosynthesis cause early‐onset multisystem disorders known as inherited GPI deficiencies. We describe a novel neuromuscular phenotype associated with PIGB deficiency.
Gorka Fernández‐Eulate +34 more
wiley +1 more source
Acetylcholinesterase Inhibitors [PDF]
Sir: Behavioral disturbances are seen in up to 90% of patients with Alzheimer' type dementia at some point during the illness.1,2 There is evidence that cholinesterase inhibitors may help in controlling dementia associated behavioral disturbances.3–5 We present a case report of a patient with behavioral disturbance associated with severe Alzheimer ...
Sanjay, Gupta +2 more
openaire +2 more sources
Cholinesterases and amyloid beta are one of the major biological targets in the search for a new and efficacious treatment of Alzheimer’s disease. The study describes synthesis and pharmacological evaluation of new compounds designed as dual binding site
Michalina Hebda +10 more
doaj +1 more source

